PL442091A1 - Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus - Google Patents

Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Info

Publication number
PL442091A1
PL442091A1 PL442091A PL44209122A PL442091A1 PL 442091 A1 PL442091 A1 PL 442091A1 PL 442091 A PL442091 A PL 442091A PL 44209122 A PL44209122 A PL 44209122A PL 442091 A1 PL442091 A1 PL 442091A1
Authority
PL
Poland
Prior art keywords
uberis
agalactiae
aureus
coli
diagnostic composition
Prior art date
Application number
PL442091A
Other languages
English (en)
Inventor
Anna DOBRUT
Dagmara Wójcik-Grzybek
Monika BRZYCHCZY-WŁOCH
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL442091A priority Critical patent/PL442091A1/pl
Priority to EP23461639.9A priority patent/EP4343328A3/en
Publication of PL442091A1 publication Critical patent/PL442091A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

W zgłoszeniu ujawniono sposób i kompozycję diagnostyczną do wykrywania mastitis wywoływanego przez E. coli, S. uberis, S. agalactiae lub S. aureus, posiadające co najmniej 80% czułość i specyficzność oraz nadające się do łatwego i szybkiego wykonywania testu wykrywającego zapalenie wymion u krów wywoływanego przez wskazane patogeny
PL442091A 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus PL442091A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL442091A PL442091A1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus
EP23461639.9A EP4343328A3 (en) 2022-08-25 2023-08-25 Diagnostic method and composition for the detection of mastitis caused by e. coli, s. uberis, s. agalactiae or s. aureus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442091A PL442091A1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Publications (1)

Publication Number Publication Date
PL442091A1 true PL442091A1 (pl) 2024-02-26

Family

ID=88207674

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442091A PL442091A1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Country Status (2)

Country Link
EP (1) EP4343328A3 (pl)
PL (1) PL442091A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713355A (pt) 1996-11-14 2000-01-25 Univ Saskatchewan Proteìna de ligação à lactoferrina d streptococcus uberis
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
US7601804B2 (en) 2002-08-12 2009-10-13 Intervet International B.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
US20050260695A1 (en) 2003-09-23 2005-11-24 Genprime, Inc. Methods, compositions, devices, and kits for detecting mastitis
US8445215B1 (en) * 2010-07-23 2013-05-21 Nestec S.A. Assays and methods for the detection of Crohn's disease
CA2845259A1 (en) 2011-08-15 2013-02-21 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein a
WO2019216775A1 (en) 2018-05-10 2019-11-14 Koru Diagnostics Limited Device for detection of antibodies to a pathogen

Also Published As

Publication number Publication date
EP4343328A3 (en) 2024-04-10
EP4343328A2 (en) 2024-03-27

Similar Documents

Publication Publication Date Title
BR102021005055A2 (pt) detecção de anticorpos para sarsr-cov
Bochniarz et al. Coagulase-negative staphylococci (CNS) as an aetiological factor of mastitis in cows
Cortimiglia et al. Prevalence of Staphylococcus aureus and methicillin-resistant S. aureus in bulk tank milk from dairy goat farms in Northern Italy
Liu et al. Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients
Sunnerhagen et al. Clinical and microbiological features of infective endocarditis caused by aerococci
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
Biswal et al. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris
Ali et al. Prevalence of mastitis pathogens and antimicrobial susceptibility of isolates from cattle and buffaloes in Northwest of Pakistan
WO2018111630A3 (en) Rnase for improved microbial detection and antimicrobial susceptibility testing
Rysanek et al. Monitoring major mastitis pathogens at the population level based on examination of bulk tank milk samples
Krukowski et al. The first outbreak of methicillin-resistant Staphylococcus aureus in dairy cattle in Poland with evidence of on-farm and intrahousehold transmission
Shrivastava et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus (MRSA) mastitis in dairy cattle in Jabalpur, Madhya Pradesh
McDougall et al. Prevalence and incidence of intramammary infections in lactating dairy goats
Petti et al. Low methicillin-resistant Staphylococcus aureus carriage rate among Italian dental students
EP3895762A3 (en) Antibody specific to alpha-toxin of staphylococcal aureus and uses thereof
Sharma et al. Prevalence, etiology and antibiogram of bacterial isolates recovered from mastitis of buffaloes
Furuno et al. A Japanese trial to monitor methicillin-resistant Staphylococcus aureus (MRSA) in imported swine during the quarantine period
PL442091A1 (pl) Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus
Gera et al. Assessment of acute phase proteins and nitric oxide as indicator of subclinical mastitis in Holstein× Haryana cattle
Caballero et al. Effectiveness of alpha-toxin Fab monoclonal antibody therapy in limiting the pathology of Staphylococcus aureus keratitis
FR3088803B1 (fr) Nouvelle composition pour la défense des plantes contre des agents pathogènes
Khaki et al. Comparison of two disc diffusion methods with minimum inhibitory concentration for antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates
Schoiswohl et al. Suspected resistance against moxidectin in sheep strongylid nematodes in Austria
Mongkolrattanothai et al. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates
Sana et al. In Vitro comparison of disk diffusion method and agar dilution method for sensitivity of polymyxin B against Multi Drug Resistant Acinetobacter Baumannii